OSCR:NYSE
Oscar Health Inc
$33.79
arrow_downward
-0.65%(-0.22) 1D
$33.79
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 13, 4:00:10 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OSCR...
Open
$34.50
High
$35.01
Low
$33.35
Mkt. cap
10.43B
Avg. vol.
5.26M
Volume
5.47M
P/E ratio
24.68
52-wk high
$35.01
52-wk low
$10.69
EPS
$1.37
Beta
2.47
Shares outstanding
273.47M
No. of employees
2K
Open
$34.50
High
$35.01
Low
$33.35
Mkt. cap
10.43B
Avg. vol.
5.26M
Volume
5.47M
P/E ratio
24.68
52-wk high
$35.01
52-wk low
$10.69
EPS
$1.37
Beta
2.47
Shares outstanding
273.47M
No. of employees
2K
News stories
From web sources and news partners
Zacks
·
8 hours ago
Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going?
Yahoo Finance
·
9 hours ago
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve
Profile
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems. Wikipedia
About Oscar Health Inc
CEOMark Bertolini
Employees2.3K
FoundedNov 1, 2012
HeadquartersNew York, New York, United States
SectorInsurance
Websitehioscar.com
Analyst ratings
Based on 10 analysts giving stock ratings to OSCR in the past 3 months
Hold
Buy
3
Hold
6
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for OSCR in the last 3 months.
Highest
Current $33.79
$49.00 (+45.01%)
Average
$35.78 (+5.89%)
Lowest
$27.00 (-20.09%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Jonathan Yong UBS | Hold | Reiterated | $36.00 | +6.5% | 10/12/2026 |
Jessica Tassan Piper Sandler | Buy | Maintained | $48.00 | +42.1% | 09/23/2026 |
Parker Snure Raymond James | Buy | Maintained | - | - | 09/22/2026 |
David Windley Jefferies | Hold | Maintained | $31.00 | -8.3% | 09/17/2026 |
Michael Ha Robert W. Baird | Hold | Maintained | $33.00 | -2.3% | 09/17/2026 |
Scott Fidel Goldman Sachs | Hold | Maintained | $34.00 | +0.6% | 09/17/2026 |
Kevin Fischbeck Bank of America Securities | Sell | Reiterated | $30.00 | -11.2% | 09/17/2026 |
Andrew Mok CFA Barclays | Buy | Maintained | $49.00 | +45% | 09/17/2026 |
Stephen Baxter Wells Fargo | Hold | Reiterated | $27.00 | -20.1% | 09/16/2026 |
Kyle Evans Stephens | Hold | Reiterated | $34.00 | +0.6% | 08/07/2026 |
Adam Ron Bank of America Securities | Sell | Maintained | $25.00 | -26% | 08/06/2026 |
Michael Craig Jones Bank of America Securities | Sell | Maintained | $13.00 | -61.5% | 05/07/2026 |
Justin Lake Wolfe Research | Hold | Initiated | - | - | 05/05/2026 |
John Ransom Raymond James | Buy | Upgraded | $18.00 | -46.7% | 02/12/2026 |
Raj Kumar CFA Stephens | Hold | Maintained | $17.00 | -49.7% | 02/11/2026 |
Last report
Aug 6, 2026
Fiscal period
Q2 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$1.10 / $0.38
+189.17%beat
arrow_upward
Revenue / Est. (USD)
4.88B / 4.75B
+2.72%beat
arrow_upward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.99B | 2.81B | 4.65B | 4.88B |
Cost of goods sold | 2.59B | 2.62B | 3.23B | 3.79B |
Cost of revenue | 2.59B | 2.62B | 3.23B | 3.79B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 521.59M | 511.03M | 706.23M | 691.08M |
Operating expense | 528.90M | 518.91M | 713.25M | 697.14M |
Total operating expenses | 3.12B | 3.14B | 3.94B | 4.49B |
Operating income | -129.25M | -333.75M | 704.08M | 388.64M |
Other non operating income | -3.18M | -20.03M | 71.00K | -915.00K |
EBT including unusual items | -139.29M | -352.68M | 698.77M | 383.01M |
EBT excluding unusual items | -139.29M | -352.68M | 698.77M | 383.01M |
Income tax expense | -1.81M | -247.00K | 19.75M | 21.18M |
Effective tax rate | 1.30% | 0.07% | 2.83% | 5.53% |
Other operating expenses | - | - | - | - |
Net income | -137.45M | -352.61M | 679.00M | 361.81M |
Net profit margin | -4.60% | -12.57% | 14.61% | 7.41% |
Earnings per share | -0.53 | -1.24 | 2.07 | 1.10 |
Interest and investment income | - | 1.10M | - | - |
Interest expense | -6.86M | - | -5.38M | -4.71M |
Net interest expenses | -6.86M | 1.10M | -5.38M | -4.71M |
Depreciation and amortization charges | 7.31M | 7.88M | 7.02M | 6.06M |
EBITDA | -121.94M | -325.87M | 711.10M | 394.67M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1